In the last trading session, 2.06 million shares of the Vaxxinity Inc (NASDAQ:VAXX) were traded, and its beta was 2.70. Most recently the company’s share price was $0.20, and it changed around -$0.07 or -25.82% from the last close, which brings the market valuation of the company to $25.35M. VAXX currently trades at a discount to its 52-week high of $3.10, offering almost -1450.0% off that amount. The share price’s 52-week low was $0.19, which indicates that the current value has risen by an impressive 5.0% since then. We note from Vaxxinity Inc’s average daily trading volume that its 3-month average coming to 541.94K.

Vaxxinity Inc (NASDAQ:VAXX) trade information

Instantly VAXX has showed a red trend with a performance of -25.82% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -76.47% year-to-date, but still down -54.52% over the last five days. On the other hand, Vaxxinity Inc (NASDAQ:VAXX) is -71.81% down in the 30-day period.

Vaxxinity Inc (VAXX) estimates and forecasts

Vaxxinity Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -78.11 percent over the past six months and at a 6.67% annual growth rate that is well below the industry average of 13.00%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 37.50% in revenue this quarter, and will report an increase of 33.30% in the next quarter.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -41.17%.

VAXX Dividends

Vaxxinity Inc’s next quarterly earnings report is expected to be released in May.